Preview

Современная ревматология

Расширенный поиск

Фармакоэпидемиологические показатели применения сильных опиоидов в Санкт-Петербурге и различия в подходах к их использованию при ревматических заболеваниях, сопровождающихся интенсивной хронической болью

https://doi.org/10.14412/1996-7012-2010-611

Полный текст:

Литература

1. <div><p>Bergman U et al., eds. Studies in drug utilization. Methods and applications. Copenhagen, WHO Regional Office for Europe, 1979 (WHO Regional Publications, European Series Nо 8).</p><p>De Conno F., Ripamonti C., Brunelli C. Opioid purchases and expenditure in nine western European countries: "Are we killing off morphine?" J Palliative Medicine 2005; 19: 179-84.</p><p>Hamunen K., Laitinen-Parkkonen P., Paakkari P. et al. What do different databases tell about the use of opioids in seven European countries in 2002? Eur J Pain 2008; 12(6): 705-15.</p><p>Hamunen K., Paakkari P., Kalso E. Trends in opioid consumption in the Nordic countries 2002- 2006. Eur J Pain 2009; 13(9): 954-62.</p><p>Hudec R., Tisonova J., Bozekova L. et al. Trends in consumption of analgesics in Slovak Republic during 1998-2002. Eur J Clin Pharmacol 2004; 60(6): 445-8.</p><p>Яхно Н.Н., Насонов Е.Л. Неспецифическая боль в нижней части спины. Диагностика, лечение, предупреждение. М.: ООО «КомплектСервис», 2008.</p><p>Ананьева Л.П. Применение наркотических анальгетиков при лечении хронической неонкологической боли. РМЖ 2008; 16 (спец. выпуск): 21-7.</p><p>Дроздов В.Н. Основные принципы применения опиатов при хронической неонкологической боли. РМЖ 2007; 15(4): 237-41.</p><p>Кукушкин М.Л. Принципы использования опиоидов при хронической нераковой боли. РМЖ 2007; 24: 1766-72.</p><p>Эрдес Ш.Ф. Использование опиоидных анальгетиков в ревматологической практике. Боль 2008; 1(18): 24-8.</p><p>Kalso E., Allan L., Dellemijn P.L.I. Recommendations for using opioids in chronic non- cancer pain. Eur J Pain 2003; 7: 381-6.</p><p>Simpson R.K. Opioids for persistent non-cancer pain: recommendations for clinical practice. Br J Anaesth 2004; 92: 326-8.</p><p>Caldwell J.R., Hale M.E., Boyd R.E. et al. Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial. J Rheumatology 1999; 26: 862-9.</p><p>Caldwell J.R., Rapoport R.J., Davis J.C. et al. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial. J Pain Symptom Manage 2002; 23: 278-91.</p><p>Peloso P.M., Bellamy N., Bensen W. et al. Double blind randomized placebo-control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee. J Rheumatol 2000; 27: 764-71.</p><p>Jamison R.N., Raymond S.A., Slawsby E.A. et al. Opioid therapy for chronic noncancer back pain: a randomized prospective study. A randomized - prospective study. Spine 1998; 23: 2591-600.</p><p>Argoff C.E., Katz N., Backonja M. Treatment of post-herpetic Neuralgia: A Review of therapeutic Options. J Pain Symptom Manage 2004; 28(4): 396-411.</p><p>Morley J.S., Bridson J., Nash T.P et al. Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial. Palliat Med 2003; 17: 576-87.</p><p>Rowbotham M.C., Twilling L., Davies P.S. et al. Oral Opioid Therapy for chronic peripheral and central neuropathic Pain. N Engl J Med 2003; 348: 1223-32.</p><p>Furlan A.D., Sandoval J.A., Mailis-Gagnon A., Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006; 174: 11.</p><p>Breivik H. Opioids in chronic non-cancer Pain, Indications and Controversies. Eur J Pain 2005; 9: 127-30.</p><p>Kalso E., Edwards J.E., Moore R.A. et al. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004; 112: 372-80.</p><p>Butler S.F., Budman S.H., Fernandez K. et al. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 2004; 112(1-2): 65-75.</p><p>Chabal C., Erjavec M.K., Jacobson L. et al. Prescription opiate abuse in chronic pain patients: clinical criteria, incidence and predictors. Clin J Pain 1997; 13: 150-5.</p><p>Compton P., Darakjian J., Miotto K. Screening for addiction in patients with chronic pain with problematic substance use: evaluation of a pilot assessment tool. J Pain Symptom Manage 1998; 16: 355-63.</p><p>Fishbain D.A., Rosomoff H.L., Rosomoff R.S. Drug abuse, dependence and addiction in chronic pain patients. Clin J Pain 1992; 8: 77-85.</p><p>Gilson A.M., Ryan K.M., Joranson D.E. et al. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control. J Pain Symptom Manage 2004; 28: 176-88.</p><p>Gourlay D.L., Heit H.A., Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med 2005; 6: 107-12.</p><p>Katz N.P., Sherburne S., Beach M. et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg 2003; 97: 1097-102.</p><p>Makin M.K. New Directions in Opioid Use. J Roy Soc Med 2001; 94: 17-21.</p><p>Adams Gatchel R.J., Robinson R.C. Development of self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Symptom Manage 2004; 27: 440-59.</p><p>Brown R.L., Rounds L.A. Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in primary care practice. Wis Med J 1995; 94: 135-40.</p><p>Coombs R.B., Jarry J.L., Santhiapillai A.C. et al. The SISAP: a new screening instrument for identifying potential opioid abuse in the management of chronic nonmalignant pain in general medical practice. Pain Res Manage 1996; 1: 155-62.</p><p>Coluzzi F., Pappagallo M. Opioid therapy for chronic noncancer pain: practice quidelines for initiation and maintenance of therapy. Minerva Anestesiol 2005; 71: 425-33.</p><p>Kahan M., Srivastava A., Wilson L. et al. Opioids for managing chronic non-malignant pain: safe and effective prescribing. Can Fam Physician 2006 Dec; 52(12): 1091-6.</p><p>Tedeschi M. Chronic nonmalignant pain - the rational use of opioid medication. Aust Fam Physician 2006 Jul; 35(7): 509-12.</p><p>Portenoy R.K., Farrar J.T, Backonja M.M. et al. Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study. Clin J Pain 2007 May; 23(4): 300-2.</p><p>Hale M.E., Tudor I.C., Khanna S. et al. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis. Clin Ther 2007 May; 29(5): 874-88.</p><p>Roth S.H., Fleischmann R.M., Burch F.X. et al. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation. Arch Intern Med 2000 Mar 27; 160(6): 853-60.</p><p>Ytterberg S.R., Mahowald M.L., Woods S.R. Codeine and oxycodone use in patients with chronic rheumatic disease pain. Arthr Rheum 1999 Apr; 42(4): 830-1.</p><p>Kivitz A., Ma C., Ahdieh H. et al. Phase III trial comparing efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Clin Ther 2006 Mar; 28(3): 352-64.</p><p>Allan L., Hays H., Jensen N.H. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ 2001 May; 12; 322(7295): 1134-58.</p><p>Rauck R.L., Bookbinder S.A., Bunker T.R. et al. A randomized, open-label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial. J Opioid Manag 2006 Nov-Dec; 2(6): 325-8,331-3.</p><p>Rauck R.L., Bookbinder S.A., Bunker T.R. et al. The ACTION study: a randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain. J Opioid Manag 2006 Sep-Oct; 2(5): 276.</p><p>Rosenthal M., Moore P., Groves E. et al. Sleep improves when patients with chronic OA pain are managed with morning dosing of once a day extended-release morphine sulfate (AVINZA): findings from a pilot study. J Opioid Manag 2007 May- Jun; 3(3): 145-54.</p><p>Simpson R.K. Jr., Edmondson E.A., Constant C.F. et al. Transdermal fentanyl as treatment for chronic low back pain. Pain Symptom Manage 1997 Oct; 14(4): 218-24.</p><p>Nicholson B., Ross E., Weil A. et al. Treatment of chronic moderate-to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsules. Curr Med Res Opin 2006 Mar; 22(3): 539-50.</p><p>Nicholson B., Ross E., Sasaki J. et al. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe non- malignant pain. Curr Med Res Opin 2006 Aug; 22(8): 1503-14.</p><p>Milligan K., Lanteri-Minet M., Borchert K. et al. Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic noncancer pain. J Pain 2001 Aug; 2(4): 195-6.</p><p>Langford R., McKenna F., Ratcliffe S. et al. Transdermal Fentanyl for Imrovement of Pain and Functioning in Osteoartrithis. Arthr Rheum 2006 June; 54(6): 1829-37.</p><p>Le Loёt X., Pavelka K., Richarz U. Transdermal fentanyl for the treatment of pain caused by osteoarthritis of the knee or hip: an open, multicentre study. Musculoskelet Disord 2005 Jun 15; 6: 31.</p><p>Choquette D., McCarthy T.G., Rodrigues J.F et al. Transdermal fentanyl improves pain control and functionality in patients with osteoarthritis: an open-label Canadian trial. Clin Rheumatol 2007Nov; 23.</p><p>Theoridis T., Waap I., Schwalen S. et al. Fentanyl-TTS in the treatment of pain caused by arthrosis. Z Orthop Ihre Grenzgeb 2003 Mar- Apr; 141(2): 217-22.</p><p>Berliner M.N., Giesecke T., Bornhövd K.D. Impact of transdermal fentanyl on quality of life in rheumatoid arthritis. Clin J Pain 2007 Jul- Aug; 23(6): 530-4.</p><p>Herrero-Beaumont G., Bjorneboe O., Richarz U. Transdermal fehtanyl for the treatment of pain caused by rheumatoid arthritis. Rheumatol Int 2004 Nov; 24(6): 325-32.</p><p>Pavelka K., Le Loet X., Bjorneboe O. et al. Benefits of transdermal fentanyl in patients with rheumatoid arthritis or with osteoarthritis of the knee or hip: an open-label study to assess pain. Curr Med Res Opin 2004 Dec; 20(12): 1967-77.</p></div><br />


Для цитирования:


Пчелинцев М.В., Звартау Е.Е., Кубынин А.Н. Фармакоэпидемиологические показатели применения сильных опиоидов в Санкт-Петербурге и различия в подходах к их использованию при ревматических заболеваниях, сопровождающихся интенсивной хронической болью. Современная ревматология. 2010;4(2):100-104. https://doi.org/10.14412/1996-7012-2010-611

For citation:


Pchelintsev M.V., Zvartau E.E., Kubynin A.N. Farmakoepidemiologicheskie pokazateli primeneniya sil'nykh opioidov v Sankt-Peterburge i razlichiya v podkhodakh k ikh ispol'zovaniyu pri revmaticheskikh zabolevaniyakh, soprovozhdayushchikhsya intensivnoy khronicheskoy bol'yu. Modern Rheumatology Journal. 2010;4(2):100-104. (In Russ.) https://doi.org/10.14412/1996-7012-2010-611

Просмотров: 613


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)